Updated on 22 October 2026
Health Data Integration, Interoperability & Clinical Applications | Horizon Europe Health 2027 Technology Partner
Innovation Unit Coordinator | EU Funding Manager at Datawizard Srl
Rome, Italy
About
Our contribution to Horizon Europe consortia includes:
-
Health data integration: APIs, modular architectures and integration with healthcare information systems.
-
Interoperability: digital services enabling data exchange and integration across healthcare applications.
-
Clinical applications & visualisation: dashboards, user interfaces and tools for accessing and interpreting research and clinical data.
-
Technology integration & validation: incorporation of predictive models and diagnostic outputs into clinical workflows, software development and pilot testing.
Our added value: Bridging research, technology and real-world healthcare implementation through a combination of technical expertise, user-centred design and understanding of clinical processes.
Target Horizon Europe 2027 topics:
-
HORIZON-HLTH-2027-02-TOOL-01
-
HORIZON-HLTH-2027-02-IND-02
-
HORIZON-HLTH-2027-03-TOOL-04
Collaboration sought: We are interested in joining consortia as a technical development and integration partner, taking responsibility for dedicated tasks or work packages covering interoperability, digital applications, data visualisation and clinical workflow integration.
Topic
- Destination 5: HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
- Destination 6: HORIZON-HLTH-2027-02-IND-02-two-stage: Portable and versatile Point-of-care diagnostics
- Destination 5: HORIZON-HLTH-2027-03-TOOL-04: Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis
Type
- Partner seeks Consortium/Coordinator
Organisation
Similar opportunities
Project cooperation
- Partner seeks Consortium/Coordinator
- Destination 5: HORIZON-HLTH-2027-03-TOOL-04: Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis
- Destination 4: HORIZON-HLTH-2027-01-CARE-02: Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
- Destination 5: HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
Michela Mattaloni
Innovation Unit Coordinator | EU Funding Manager at Datawizard Srl
Rome, Italy
Project cooperation
Digital Health, Patient Engagement & Care Pathways | Cluster Health 2027 Technology Partner
- Partner seeks Consortium/Coordinator
- Destination 3: HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseases
- Destination 3: HORIZON-HLTH-2027-02-DISEASE-14-two-stage: Clinical trials for advancing innovative interventions for neurodegenerative
- Destination 1: HORIZON-HLTH-2027-01-STAYHLTH-01: Addressing disabilities through the life course to support independent living and inclusion
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-10: Prevention and management of chronic non-communicable diseases in children and young people (GACD)
Michela Mattaloni
Innovation Unit Coordinator | EU Funding Manager at Datawizard Srl
Rome, Italy
Project cooperation
Translational PET/CT and PET/MR imaging: from mouse models to patients
- Partner seeks Consortium/Coordinator
- Destination 3: HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseases
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-06: Development of monoclonal antibodies to prevent and treat infections from Flaviviruses
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-08: Development of innovative antimicrobials against pathogens resistant to antimicrobials
- Destination 3: HORIZON-HLTH-2027-02-DISEASE-14-two-stage: Clinical trials for advancing innovative interventions for neurodegenerative
- Destination 5: HORIZON-HLTH-2027-03-TOOL-04: Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-05: Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-07: Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga viruses
- Destination 5: HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
Anastasios Gaitanis
Research Scientist, Level A' at Biomedical Research Foundation of the Academy of Athens
Athens, Greece